PM: decision on the application for modification of an agreed PIP
Decision date
Compliance procedure number
EMEA-C-000901-PIP03-16-M02
Compliance opinion date
Compliance outcome
Positive
Decision
P/0172/2021: EMA decision of 9 April 2021 on the acceptance of a modification of an agreed paediatric investigation plan for ruxolitinib (phosphate) (Jakavi), (EMEA-000901-PIP03-16-M02)